C-H9YFBooster Therapeutics
20S proteasome activation, small molecules, protein homeostasis
repairingsmall molecule
Loading
Загрузка раздела...0-100 chain-logic scale · 15 dimensions · scored on public evidence
All companiesC-H9YF
C-H9YFC-H9YF20S proteasome activation, small molecules, protein homeostasis
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Booster Therapeutics states that aging and many age-related diseases are driven in part by a collapse of cellular homeostasis, especially the age-related loss of the cell's ability to eliminate damaged components. The company argues that treating diseases one by one is the wrong paradigm and that targeting the cellular machinery that regulates and maintains homeostasis can prevent and treat diseases of aging. It further suggests that preserved homeostatic function in centenarians and long-lived animals, and its association with longevity across organisms, supports this therapeutic approach.
SourceBooster Therapeutics утверждает, что многие заболевания старения не следует рассматривать только как отдельные состояния, поскольку само старение частично обусловлено нарушением cellular homeostasis. Компания считает, что с возрастом клетки утрачивают способность удалять повреждённые клеточные компоненты, из-за чего нефункциональный материал накапливается и дестабилизирует нормальную работу клеток. Компания также утверждает, что сохранение или модуляция клеточного механизма, регулирующего homeostasis, связаны с долголетием у разных организмов и могут помочь в лечении заболеваний, которые в настоящее время считаются неизлечимыми.
SourceBooster Therapeutics states that aging and many age-related diseases are driven in part by a collapse of cellular homeostasis, especially the declining ability of cells to eliminate damaged cellular components. The company argues that treating diseases one by one contributes to rising age-related disease burden, and that a better approach is to target the cellular system that regulates and maintains homeostasis. It further claims that this machinery declines with age in healthy humans, remains steadier in centenarians and long-lived animals, and that modulating it is linked to longevity across multiple organisms, leading Booster to believe such modulation can help patients with currently untreatable diseases.
SourceBooster Therapeutics states that aging and many age-related diseases are driven by a collapse of cellular homeostasis, especially the age-related loss of the cell’s ability to eliminate damaged components. The company believes treating diseases one by one contributes to rising age-related burden, and that targeting the cellular machinery that regulates and maintains homeostasis can prevent and treat diseases of aging. It further asserts that this machinery declines with age in healthy humans but remains stable in centenarians and long-lived animals, and that modulating it is linked to longevity across organisms.
Source